What does a neuropsych test show?
A neuropsychological evaluation is a test to measure how well a person’s brain is working. The abilities tested include reading, language usage, attention, learning, processing speed, reasoning, remembering, problem-solving, mood and personality and more.
How much does neuropsychiatric testing cost?
Typical Costs: $3,000.00-$4,500.00. Insurance Reimbursement: Your insurance, if it is a PPO plan, may give you some reimbursement for a neuropsych evaluation. Typically, with standard out of network benefits, you will receive 65% of the contracted rate which is around $500.00-$600.00 total.
What conditions does a neuropsychologist treat?
Some of the conditions neuropsychologists routinely deal with include developmental disorders like autism, learning and attention disorders, concussion and traumatic brain injury, epilepsy, brain cancer, stroke and dementia.
What are the different types of neuropsychological tests?
Neuropsychological tests include: Halsted-Reitan neuropsychological battery or its components; Luria-Nebraska; Wechsler Adult Intelligence Scale (WAIS); Wechsler Intelligence Scales for Children – Revised (WISC-R); Wechsler Memory Scale; and the Reitan-Indiana neuropsychological test.
How long does it take to do neuropsychological testing?
Neuropsychological testing typically takes up to 8 hours to perform, including administration, scoring and interpretation. It is not necessary, as a general rule, to repeat neuropsychological testing at intervals less than 3 months apart.
Who is the best person for psychological testing?
All psychological tests should be administered, scored, and interpreted by a qualified professional, such as a licensed psychologist or psychiatrist, with expertise in the appropriate area. Psychological tests are only one element of a psychological assessment.
Why does Aetna use computerized neuropsychological assessment devices?
Aetna considers the use of computerized neuropsychological assessment devices experimental and investigational for screening and monitoring multiple sclerosis-related cognitive impairment because the effectiveness of this approach has not been established.